Please use this identifier to cite or link to this item:
Title: Lipoprotein(a) - Link between Atherogenesis and Thrombosis
Authors: Labudovic, Danica 
Irena Kostovska 
Katerina Tosheska Trajkovska 
Cekovska, Svetlana 
Brezovska Kavrakova, Julijana 
Sonja Topuzovska 
Keywords: lipoprotein (a)
Issue Date: 2019
Publisher: Charles University in Prague, Karolinum Press
Journal: Prague Medical Report
Abstract: Lipoprotein(a) - Lp(a) - is an independent risk factor for cardiovascular disease (CVD). Indeed, individuals with plasma concentrations of Lp(a) > 200 mg/l carry an increased risk of developing CVD. Circulating levels of Lp(a) are remarkably resistant to common lipid lowering therapies, currently available treatment for reduction of Lp(a) is plasma apheresis, which is costly and labour intensive. The Lp(a) molecule is composed of two parts: LDL/apoB-100 core and glycoprotein, apolipoprotein(a) - Apo(a), both of them can interact with components of the coagulation cascade, inflammatory pathways and blood vessel cells (smooth muscle cells and endothelial cells). Therefore, it is very important to determine the molecular pathways by which Lp(a) affect the vascular system in order to design therapeutics for targeting the Lp(a) cellular effects. This paper summarises the cellular effects and molecular mechanisms by which Lp(a) participate in atherogenesis, thrombogenesis, inflammation and development of cardiovascular diseases.
ISSN: 1214-6994
DOI: 10.14712/23362936.2019.9
Appears in Collections:Faculty of Medicine: Journal Articles

Files in This Item:
File Description SizeFormat 
PMR_2019_2-3_labudovic.pdf291.39 kBAdobe PDFThumbnail
Show full item record

Page view(s)

checked on Mar 7, 2021


checked on Mar 7, 2021

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.